Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Uveal Neoplasms × Dermatologic × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 27 Skin Neoplasms 9 Uveal Melanoma 7 Carcinoma, Basal Cell 3 Recurrence 2 Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Neoplasms 1 Ulcer 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Skin Cancer Face 1 Parkinson Disease 1 Pain 1 Nevus 1 Neoplasm Metastasis 1 Mucosal Melanoma 1 Margins of Excision 1 Lymphoma, T-Cell 1 Leukemia, Myeloid, Acute 1 Keratosis, Actinic 1 Keratoacanthoma 1 Inflammatory Bowel Diseases 1 Infections 1 Immunoblastic Lymphadenopathy 1 Hypertension 1 Eye Neoplasms 1 Enteropathy-Associated T-Cell Lymphoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01785316 2024-01-26

SCANDIUM

Vastra Gotaland Region

Phase 3 Completed

Melanoma, Uveal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡